172@29@16@58!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_ANNOUNCEMENT&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Bharat Immunologicals and Biologicals Corporation Ltd.

BSE Live

Sep 23, 16:00
29.95 -0.60 (-1.96%)
Volume
AVERAGE VOLUME
5-Day
30,257
10-Day
143,383
30-Day
133,973
40,738
  • Prev. Close

    30.55

  • Open Price

    29.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    -

  • Open Price

    -

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

Bharat Immunologicals and Biologicals Corporation is not listed on NSE

ANNOUNCEMENTS ON Bharat Immuno

  • Sep 04, 2020 14:42 Source: BSE

    Bharat Immunologicals and Biologicals Corporation - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 11Th September 2020 For The Quarter Ended June 2020, Under Regulation 29 Of SEBI'S LODR.

    BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/09/2020 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 11th September 2020, to approve the Unaudited Quarterly Financial Results of the Company for the quarter ended 30th June 2020.

  • Jul 10, 2020 17:12 Source: BSE

    Bharat Immunologicals and Biologicals Corporation - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 20Th July 2020 For The Quarter Ended March 2020, Under Regulation 29 Of SEBI'S LODR.

    BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2020 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 20th July 2020, to approve the Annual Financial Results of the Company for the year ended 31st March 2020.

  • Jan 23, 2020 15:53 Source: BSE

    Bharat Immunologicals and Biologicals Corporation - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 31St January 2020 For The Quarter Ended December 2019, Under Regulation 29 Of SEBI'S LODR.

    BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2020 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 31st January 2020, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st December 2019.

  • Apr 04, 2019 17:54 Source: BSE

    Bharat Immunologicals and Biologicals Corporation - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 11Th April 2019 For The Quarter Ended March 2019, Under Regulation 29 Of SEBI'S LODR.

    BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/04/2019 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 11th April 2019, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st March 2019.

  • Jan 23, 2019 16:16 Source: BSE

    Bharat Immunologicals and Biologicals Corporation - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 31St January 2019 For The Quarter Ended December 2018, Under Regulation 29 Of SEBI'S LODR.

    BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2019 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 31st January 2019, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st December 2018.

  • Dec 26, 2017 15:56 Source: BSE

    Bharat Immunologicals and Biologicals Corporation - Intimation Of Date Of Board Meeting On 15.01.2018, Under Regulation 29 Of SEBI'S LODR.

    Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 15th January 2018, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st December 2017.

  • Oct 14, 2017 18:39 Source: BSE

    Bharat Immunologicals and Biologicals Corporation - Board Meeting On 25 October 2017

    Bharat Immunologicals & Biologicals Corporation Limited BIBCOL CIN - L24232UP1989GOI010542 (A Govt. of India Undertaking) Regd. Office: Vill. Chola, Bulandshahr(UP)-Pin 203203 Website - www.bibcol.com Phone 09458096110 No.BIB/CS/STO.EXCHA./BM/Q2/2017-18 Dated: 14.10.2017 To, The Listing Department Bombay Stock Exchange Phiroze Jeejeebhoy Towers, 25, Dalal Street, Mumbai - 400 001. Sub: Intimation of date of Board Meeting under Regulation 29 of SEBI''s LODR. Sir, Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 25th October 2017 at Delhi, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 30th September 2017. Requested to take the above on record please. Thanking you, Yours'' Sincerely, SANDIP KUMAR LAL Dy. G.M./Company Secretary

  • Jul 10, 2017 13:39 Source: BSE

    Bharat Immuno - Intimation Of Date Of Board Meeting(25.07.2017) Under Regulation 29 Of SEBI'S LODR.

    Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 25th July 2017 at Delhi, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 30th June 2017.

  • Apr 05, 2017 15:45 Source: BSE

    Bharat Immuno - Intimation Of Date Of Board Meeting On 03.05.2017, Under Regulation 29 Of SEBI'S LODR.

    Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 03rd May 2017 at Delhi, to approve and take on record the Un-audited Quarterly/twelve months Financial Results of the Company for the quarter/period ended 31st March 2017. Requested to take the above on record please.

  • Dec 27, 2016 11:37 Source: BSE

    Bharat Immuno - Board Meeting Intimation for Results

    Bharat Immunologicals & Biologicals Corporation Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on January 23, 2017, to approve and take on record the Un-audited Quarterly/Nine months Financial Results of the Company for the quarter/period ended December 31, 2016.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Sep 11, 2020
Remark : Quarterly Results